The ongoing clinical trials of Brain-Computer Interfaces (BCIs) such as Neuralink’s “Telepathy” implant involve establishing communication links between...
Results from the phase2 trial support the view that subcutaneous administration of IFN- β for treatment of COVID-19 enhances speed of recovery and reduces mortality....
Scientists have designed a new chest-laminated, ultrathin, 100 percent stretchable cardiac sensing electronic device (e-tattoo) to monitor heart functions. The device can measure ECG,...
Scientific research has proven that dogs are compassionate beings who overcome obstacles to help their human owners.
Humans have domesticated dogs for thousands of years...
A combination of biological and computational approach to study protein-protein interactions (PPIs) between the viral and the host proteins in order to identify and...
Asciminib (Scemblix) has been approved for adult patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase (CP). The accelerated approval...
A novel study based on nanotechnology generates hope for treating acute kidney injury and failure.
Kidney is an essential vital organ which performs critical functions...
On 11 October 2024, Hympavzi (marstacimab-hncq), a human monoclonal antibody targeting “tissue factor pathway inhibitor” received US FDA’s approval as a new drug for...
The APXC instrument aboard the lunar rover of ISRO’s Chandrayaan-3 moon mission conducted in-situ spectroscopic study to ascertain abundance of elements...